These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33374715)

  • 21. Scandium-44 Radiolabeled Peptide and Peptidomimetic Conjugates Targeting Neuropilin-1 Co-Receptor as Potential Tools for Cancer Diagnosis and Anti-Angiogenic Therapy.
    Masłowska K; Redkiewicz P; Halik PK; Witkowska E; Tymecka D; Walczak R; Choiński J; Misicka A; Gniazdowska E
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex.
    Starzec A; Ladam P; Vassy R; Badache S; Bouchemal N; Navaza A; du Penhoat CH; Perret GY
    Peptides; 2007 Dec; 28(12):2397-402. PubMed ID: 17983687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of selective VEGF-A binding by neuropilin-1 reveals a basis for specific ligand inhibition.
    Parker MW; Xu P; Guo HF; Vander Kooi CW
    PLoS One; 2012; 7(11):e49177. PubMed ID: 23145112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropilin-1 expression promotes invasiveness of melanoma cells through vascular endothelial growth factor receptor-2-dependent and -independent mechanisms.
    Ruffini F; D'Atri S; Lacal PM
    Int J Oncol; 2013 Jul; 43(1):297-306. PubMed ID: 23685409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of neuropilin-1 by basic fibroblast growth factor enhances vascular smooth muscle cell migration in response to VEGF.
    Liu W; Parikh AA; Stoeltzing O; Fan F; McCarty MF; Wey J; Hicklin DJ; Ellis LM
    Cytokine; 2005 Dec; 32(5):206-12. PubMed ID: 16289960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.
    Tirand L; Frochot C; Vanderesse R; Thomas N; Trinquet E; Pinel S; Viriot ML; Guillemin F; Barberi-Heyob M
    J Control Release; 2006 Mar; 111(1-2):153-64. PubMed ID: 16423422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis.
    Banerjee S; Mehta S; Haque I; Sengupta K; Dhar K; Kambhampati S; Van Veldhuizen PJ; Banerjee SK
    Biochemistry; 2008 Mar; 47(11):3345-51. PubMed ID: 18284215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VEGF but not PlGF disturbs the barrier of retinal endothelial cells.
    Deissler HL; Deissler H; Lang GK; Lang GE
    Exp Eye Res; 2013 Oct; 115():162-71. PubMed ID: 23891860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165.
    Lambert S; Bouttier M; Vassy R; Seigneuret M; Petrow-Sadowski C; Janvier S; Heveker N; Ruscetti FW; Perret G; Jones KS; Pique C
    Blood; 2009 May; 113(21):5176-85. PubMed ID: 19270265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New peptide MY1340 revert the inhibition effect of VEGF on dendritic cells differentiation and maturation via blocking VEGF-NRP-1 axis and inhibit tumor growth in vivo.
    Mo Z; Yu F; Han S; Yang S; Wu L; Li P; Jiao S
    Int Immunopharmacol; 2018 Jul; 60():132-140. PubMed ID: 29730556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct heparin binding sites on VEGF165 and its receptors revealed by their interaction with a non sulfated glycoaminoglycan (NaPaC).
    Di Benedetto M; Starzec A; Vassy R; Perret GY; Crépin M
    Biochim Biophys Acta; 2008 Apr; 1780(4):723-32. PubMed ID: 18325345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1.
    Bernatchez PN; Rollin S; Soker S; Sirois MG
    J Cell Biochem; 2002; 85(3):629-39. PubMed ID: 11968003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. tLyp-1: A peptide suitable to target NRP-1 receptor.
    Larue L; Kenzhebayeva B; Al-Thiabat MG; Jouan-Hureaux V; Mohd-Gazzali A; Wahab HA; Boura C; Yeligbayeva G; Nakan U; Frochot C; Acherar S
    Bioorg Chem; 2023 Jan; 130():106200. PubMed ID: 36332316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropilin-1-mediated vascular permeability factor/vascular endothelial growth factor-dependent endothelial cell migration.
    Wang L; Zeng H; Wang P; Soker S; Mukhopadhyay D
    J Biol Chem; 2003 Dec; 278(49):48848-60. PubMed ID: 14514674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output.
    Ballmer-Hofer K; Andersson AE; Ratcliffe LE; Berger P
    Blood; 2011 Jul; 118(3):816-26. PubMed ID: 21586748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic therapy targeting neuropilin-1: Interest of pseudopeptides with improved stability properties.
    Thomas N; Pernot M; Vanderesse R; Becuwe P; Kamarulzaman E; Da Silva D; François A; Frochot C; Guillemin F; Barberi-Heyob M
    Biochem Pharmacol; 2010 Jul; 80(2):226-35. PubMed ID: 20380812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration.
    Teesalu T; Sugahara KN; Kotamraju VR; Ruoslahti E
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16157-62. PubMed ID: 19805273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placenta growth factor and neuropilin-1 collaborate in promoting melanoma aggressiveness.
    Pagani E; Ruffini F; Antonini Cappellini GC; Scoppola A; Fortes C; Marchetti P; Graziani G; D'Atri S; Lacal PM
    Int J Oncol; 2016 Apr; 48(4):1581-9. PubMed ID: 26846845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and structure-activity relationship of non-peptidic antagonists of neuropilin-1 receptor.
    Liu WQ; Megale V; Borriello L; Leforban B; Montès M; Goldwaser E; Gresh N; Piquemal JP; Hadj-Slimane R; Hermine O; Garbay C; Raynaud F; Lepelletier Y; Demange L
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4254-9. PubMed ID: 25091928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NRPa-308, a new neuropilin-1 antagonist, exerts in vitro anti-angiogenic and anti-proliferative effects and in vivo anti-cancer effects in a mouse xenograft model.
    Liu WQ; Lepelletier Y; Montès M; Borriello L; Jarray R; Grépin R; Leforban B; Loukaci A; Benhida R; Hermine O; Dufour S; Pagès G; Garbay C; Raynaud F; Hadj-Slimane R; Demange L
    Cancer Lett; 2018 Feb; 414():88-98. PubMed ID: 29111348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.